Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Low-Cost Phosphite Ligands Improve Metathesis Catalysts

Phosphite ligands offer advantages over current catalysts for some challenging reactions

by Stuart A. Borman
September 27, 2010 | A version of this story appeared in Volume 88, Issue 39

A class of olefin metathesis catalysts that contains phosphite ligands has advantages over current catalysts for some challenging reactions, such as ring-closing metatheses of hindered dienes, according to chemists in Scotland. Inexpensive phosphites have not been extensively investigated as metathesis catalyst ligands. But Catherine S. J. Cazin and coworkers at the University of St. Andrews modified an existing ruthenium indenylidene metathesis catalyst with tri­iso­propyl­phos­phite groups to form cis and trans phosphite complexes that represent a new type of metathesis catalyst (Chem. Commun. 2010, 46, 7115). The catalysts, which they call cis- and trans-Caz-1, promote a difficult tosylamine ring-closing with 100% conversion, compared with about 60% achieved by existing catalysts. And a considerably smaller amount of Caz-1 is needed to promote ring-closing metathesis of hindered dienes than is required for current catalysts. The Caz-1 catalysts also show unusually good stability and longevity in reactions, and the cis form has a unique configuration that “hasn’t been observed before” in a metathesis catalyst, Cazin says. cis-Caz-1, which has been commercialized by Strem Chemicals and Umicore, went “from discovery to market in less than six months,” she notes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.